Valneva’s chikungunya jab gets FDA nod, first such for disease
HQ Team November 10, 2023: Valneva SE, a French vaccine maker, has got USFDA approval for its chikungunya vaccine, Ixchiq, to treat individuals.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team November 10, 2023: Valneva SE, a French vaccine maker, has got USFDA approval for its chikungunya vaccine, Ixchiq, to treat individuals.
HQ Team September 21, 2023: One person died and 14 others were suspected to have botulism in France, with chances of additional cases.
Nigeria has recorded an “unusual” rise in diphtheria with 5,898 cases being reported during the three months ended August.
HQ Team July 17, 2023: Migratory flows have fanned the Chagas disease, and a study of 2,820 people from the countries where it.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com (opens in a new window)